Steering Committee

Purpose

The GHTF Steering Committee is established under the Procedural Document, "Roles and Responsibilities (PDF) ". As stated in this document, "the role of the Steering Committee is to provide policy direction, strategic planning, and to assign and provide oversight of technical work initiatives". Please see the Strategic Direction document (PDF: 323kb, revised version posted December 19th, 2002) for more information. In addition, the Steering Committee will facilitate progress of work products between GHTF Conferences.

Representation on the Steering Committee is limited to up to 4 regulatory and 4 industry members from each founding geographic area - Europe, North America and the Asia-Pacific. The current Steering Committee membership list is outlined below.

The inaugural Steering Committee meeting was convened during early 2001 in Sydney, Australia and was hosted by the new GHTF Chair (as at January 2001), Ms Rita Maclachlan of Australia's Therapeutic Goods Administration.

Details

Steering Committee Chair
Membership List
Ad Hoc Working Groups
Meeting Minutes
Meeting Dates

Mtg No.	Date	Location
20	May 2011	Brisbane, Australia
19	November 2010	Sydney, Australia
18	May 2010	Singapore
17	November 2009	Vancouver, Canada
16	May 2009	Toronto, Canada
15	October 2008	Ottawa, Canada
14	March 2008	Kuala Lumpur Malaysia
13	September 2007	Washington, USA
12	May 2007	Irvine, USA
11	November 2006	Brussels, Belgium
10	June 2006	Lubeck, Germany
9	November 2005	London, United Kingdom
8	May 2005	Seville, Spain
7	June 2004	Paris, France
6	5-7 November 2003	San Francisco, USA
5	28-30 October 2002	Tokyo, Japan
4	12-13 May 2002	Singapore
3	11-12 October 2001	London, United Kingdom
2	12-13 June 2001	Brussels, Belgium
1	28 February - 2 March 2001	Sydney, Australia

Documents

Proposed Documents - (for review & comments)
Final Documents
GHTF May 2011 Steering Committee Meeting - Outcome Statement

Updated 20 May 2011

Other Sites of Interest

Disclaimers